Newsday - Device Tested To Treat Aggressive Brain Tumors

New York, NY
 – March 27, 2013 /Press Release/  –– 

Glioblastoma is the most aggressive form of brain cancer and carries a dismal prognosis. Only 26 percent of patients are alive two years after diagnosis, doctors say. Medical investigators at the Long Island Brain Tumor Center and at The Mount Sinai Hospital have embarked upon trials that, while similar, are fundamentally different in scope. Both are testing a skullcaplike device that contains embedded electrodes, so-called transducer arrays. Nine of them alternate round-the-clock permeating each patient's brain with electrical field energy. "Glioblastoma is very difficult to fight because it has a recurrence rate that is 98 percent," said Dr. Isabelle Germano, lead investigator at Mount Sinai. "Even with aggressive treatment the tumor comes back and life expectancy is very limited," Dr. Germano said. "We recommend 20 hours a day, taking it off to shower, to be free of it for a little while.” Learn more (subscription required)